A series of novel thienopyrimidin-4-amines have been synthesized and evaluated as phosphodiesterase (PDE) inhibitors. A rationale for the observed selectivity against PDE7 has been obtained from molecular modelling studies on the most active compounds.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c4ob00175c | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!